TJ-L-1-D-5

N/A

Report date: 2022/01/05 15:24:33

Base Information

Drug NameTJ-L-1-D-5
Drug Alias NameTJ-L-1-D-5
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Programmed death-ligand 15'-nucleotidase inhibitors
TargetsProgrammed death-ligand 15'-nucleotidase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesI-Mab Biopharma Hongkong Ltd
China Registration ClassN/A

Develop Information

Active CompaniesI-Mab Biopharma Hongkong Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A